ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Medical Device Recalls Highest Since 2005


Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Professionals analyzing medical graphs

More medical devices were recalled in the first quarter of this year than any time since 2005, according to a new report that also says prescription drug recalls increased.

There were 343 device recalls in the first three months of the year, an increase of 126 percent over the last quarter of 2017, according to the report from data company Stericycle Expert Solutions. There were 105 prescription drug recalls, an increase of 52 percent and the highest number since 2013.

A medical device expert said the report may tell only part of the story.

Professor: Many Problems Unreported

“My concern is this report is just showing us the tip of the iceberg, and there are a lot more adverse events associated with devices on the market that we’re not hearing about and should be,” said Dr. Rita Redberg, a cardiologist at University of California San Francisco, who has done extensive research in the area of medical device safety.

The total number of medical device units recalled in the quarter was about 208.4 million, with the average number involved in each recall being 607,512, according to the report. The vast majority of the units – 93.7 percent – were recalled due to manufacturing defects.

Software problems were the top cause for the recalls. A total of 22.7 percent of recalls were for that reason. It was the eighth quarter in a row that software was the top reason for device recalls.

Redberg told Drugwatch the report is another piece of evidence that improvements are needed. She said the government’s current system for reporting problems — known as adverse events — is inadequate. “We only hear about a few percent of what actually happens,” she said.

FDA Plan Would Reduce Reports

“My sense, even before the report, is that things are worse because there has been little attention paid to recording adverse events, to look at post-market surveillance,” she said, referring to research done after a device is being used on patients. “There is a lot of attention being paid to getting devices on the market faster.”

Redberg said a recent Medical Device Safety Action Plan from the U.S. Food and Drug Administration would reduce the requirements to report adverse events even further, based on the idea that “these devices are doing so much good.”

The 21st Century Cures Act, passed by Congress in December 2016, also reduced device safety reporting, Redberg said.

She pointed to an implanted cardiac monitor, AngelMed Guardian. In 2018, an FDA advisory panel unanimously rejected the device, finding that the benefits didn’t outweigh the risks.

A majority of the panel voted that there was not reasonable assurance that the device was safe, while the entire 12-member panel found it not effective. But last month, the FDA approved the device, saying additional analysis “demonstrate a positive risk-benefit profile for the device.”

The reasons for the approval, Redberg said, are “unclear to me.” She said, “A lot of people rushed to the emergency room” when the device alerts went off for no reason.

While Redberg said she is concerned about most devices, even some that may seem low risk, such as glucose infusion pumps. These devices can be high risk when they malfunction.

Implanted Devices Raise Most Concern

But she said her biggest worry involves implanted devices, such as joint replacements and surgical mesh. Unlike drugs, when there is a problem with a device that is inside a patient’s body, the patient can’t just stop using it. He or she has to either live with the dangerous device or undergo a risky procedure to have it removed.

Redberg said she would like the government to require post-market surveillance of all devices, making all data accessible to the public. The current system requires adverse event reporting only by manufacturers at their discretion and institutions.

Patients and medical professionals are not required to report problems.

“It is estimated that only a few percent, maybe 5 or 6 percent, of all adverse events get reported,” she said. “I don’t think you would say we have an actual system that’s working well.”

Defibrillators, Catheters Recalled

Among the serious recalls in the first quarter of 2018 were cardiac resynchronization therapy (CRT) and implantable cardioverter defibrillators made by Medtronic. These devices provide pacing for slow heart rhythms and electrical shocking or pacing to stop dangerously fast heart rhythms.

This was a Class I recall, meaning using the devices risked serious injury or death. According to the FDA, a manufacturing error prevented electrical shock delivery by the devices, which were manufactured from July 13, 2013, to Aug. 8, 2017.

Another Class I recall involved a device used to insert and position cardiovascular catheters. The device, made by Sterilmed, was a reprocessed Agilis steerable introducer sheath. A problem with that device could cause “serious health consequences for patients, including death,” according to the FDA.

Elaine Silvestrini
Written By Elaine Silvestrini Writer

Elaine Silvestrini is an award-winning journalist with 30 years of experience covering state and federal court systems. She joined Drugwatch in 2017. Her coverage for Drugwatch has been cited in the CDC’s Public Health Law News and the USA Today Network. Some of her qualifications include:

  • Centers for Disease Control and Prevention certificates in Health Literacy
  • Experience as an assistant investigator for the Federal Public Defender
  • Loyola Law School Journalist Law School Fellowship
Edited By

6 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. Cision PR Newswire. (2018, May 8). Healthcare Scare: Medical Device and Pharmaceutical Recalls Spike. Retrieved from
  2. Stericycle. (2018, Q1). Recall Index. Retrieved from
  3. Food and Drug Administration. (2018, April 18). Summary of Safety and Effectiveness Data. Retrieved from
  4. Redberg, R. (2019, May 9). Telephone Interview with Drugwatch.
  5. Food and Drug Administration. (2018, Feb. 26). Medtronic Recalls Cardiac Resynchronization Therapy and Implantable CardioVerter Defibrillators Due to Manufacturing Error Preventing Electrical Shock Delivery. Retrieved
  6. Food and Drug Administration. (2018, January 2). Sterilmed Reprocessed Agilis Steerable Introducer Sheath recalled due to improper seal of the sheath hub. Retrieved
View All Sources
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's trusted legal partners support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(888) 645-1617